Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Blood - 27 Aug 2009

Morris Timothy A, Marsh James J, Chiles Peter G, Magaña Marisa M, Liang Ni-Cheng, Soler Xavier, Desantis Daniel J, Ngo Debby, Woods Virgil L

Abstract excerpt

The mechanism by which chronic thromboembolic pulmonary hypertension (CTEPH) develops after acute pulmonary thromboembolism is unknown. We previously reported that fibrin from CTEPH patients is relatively resistant to fibrinolysis in vitro. In the present study, we performed proteomic, genomic, and functional studies on fibrin(ogen) to investigate whether abnormal fibrin(ogen) might contribute to the pathogenesis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Disorders, Inherited
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrin

Share to Fibrinogen

Share to Fibrinogens, Abnormal

Share to Hypertension, Pulmonary

Share to Prevalence

Share to Pulmonary Embolism

Source

Open in PubMed Open full text

Identifiers

PMID: 19420351
DOI: 10.1182/blood-2009-03-208264
PMCID: PMC2738577

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.PMID 19420351Read ↗

Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.Semantic proximity Read ↗

Molecular Research in Chronic Thromboembolic Pulmonary HypertensionSemantic proximity Read ↗

Heterogeneity of Genotype–Phenotype in Congenital Hypofibrinogenemia—A Review of Case Reports Associated with Bleeding and ThrombosisSemantic proximity Read ↗

Genetic and Clinical Determinants of Chronic Thromboembolic Pulmonary Hypertension: The Role of PAI-1 Polymorphism.Semantic proximity Read ↗

A genome-wide association study in chronic thromboembolic pulmonary hypertension and the ADAMTS13-VWF axisSemantic proximity Read ↗

Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and ThromboembolismSemantic proximity Read ↗

Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension.Semantic proximity Read ↗

Exome Sequencing and Clot Lysis Experiments Demonstrate the R458C Mutation of the Alpha Chain of Fibrinogen to be Associated with Impaired Fibrinolysis in a Family with Thrombophilia.Semantic proximity Read ↗

Proteomic Characterisation of Anomalous Intravascular Casts Reveals Non-Canonical Fibrin Architecture and Impaired FibrinolysisSemantic proximity Read ↗

Hypercoagulability in venous and arterial thrombosis.Semantic proximity Read ↗

The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension.Semantic proximity Read ↗

Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.